Literature DB >> 23609462

Deferoxamine: emerging, new neuro-protective benefits.

Shailendra Kapoor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609462     DOI： 10.1007/s10072-013-1441-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  16 in total

1.  The hypoxic preconditioning agent deferoxamine induces poly(ADP-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain.

Authors:  Ana Cañuelo; Rubén Martínez-Romero; Esther Martínez-Lara; José A Sánchez-Alcázar; Eva Siles
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

3.  Deferoxamine reduces cavity size in the brain after intracerebral hemorrhage in aged rats.

Authors:  Tetsuhiro Hatakeyama; Masanobu Okauchi; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.

Authors:  Leah R Hanson; Jared M Fine; Dan B Renner; Aleta L Svitak; Rachel B Burns; Thuhien M Nguyen; Nathan J Tuttle; Dianne L Marti; S Scott Panter; William H Frey
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

5.  Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs.

Authors:  Demetrios Vlahakos; Nikolaos Arkadopoulos; Georgia Kostopanagiotou; Sofia Siasiakou; Loukas Kaklamanis; Dimitrios Degiannis; Maria Demonakou; Vassilios Smyrniotis
Journal:  Artif Organs       Date:  2011-12-21       Impact factor: 3.094

6.  Effects of N-acetylcysteine/deferoxamine, taurine and RC-3095 on respiratory chain complexes and creatine kinase activities in rat brain after sepsis.

Authors:  Omar J Cassol; Gislaine T Rezin; Fabrícia C Petronilho; Giselli Scaini; Cinara L Gonçalves; Gabriela K Ferreira; Rafael Roesler; Gilberto Schwartsmann; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

7.  Deferoxamine reduces early brain injury following subarachnoid hemorrhage.

Authors:  Jin-Yul Lee; Richard F Keep; Ya Hua; Ralf-Ingo Ernestus; Guohua Xi
Journal:  Acta Neurochir Suppl       Date:  2011

8.  Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.

Authors:  J M Fine; A M Baillargeon; D B Renner; N S Hoerster; J Tokarev; S Colton; A Pelleg; A Andrews; K A Sparley; K M Krogh; W H Frey; L R Hanson
Journal:  Exp Brain Res       Date:  2012-05-01       Impact factor: 1.972

9.  Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.

Authors:  Takehiro Nakamura; Richard F Keep; Ya Hua; Timothy Schallert; Julian T Hoff; Guohua Xi
Journal:  J Neurosurg       Date:  2004-04       Impact factor: 5.115

10.  Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats.

Authors:  Masanobu Okauchi; Ya Hua; Richard F Keep; Lewis B Morgenstern; Guohua Xi
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914
View more
  1 in total

1.  Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.

Authors:  Xinguo Jiang; Andrey V Malkovskiy; Wen Tian; Yon K Sung; Wenchao Sun; Joe L Hsu; Sathish Manickam; Dhananjay Wagh; Lydia-Marie Joubert; Gregg L Semenza; Jayakumar Rajadas; Mark R Nicolls
Journal:  Biomaterials       Date:  2013-10-22       Impact factor: 12.479
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.